• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭与转移。

Invasion and metastasis.

作者信息

Carr I, Orr F W

出版信息

Can Med Assoc J. 1983 May 15;128(10):1164-7.

PMID:6340812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1875302/
Abstract

Malignant tumours cause sickness and death largely because they invade and metastasize. Such spread is made possible by many cellular properties, including the ability of neoplastic cells to move and to release degradative enzymes. These properties enable tumour cells to break free of the primary tumour, penetrate blood or lymphatic vessels and, after being transported to distant sites, pass out of the vessels to establish new tumours. Not all cells in a tumour, however, are able to metastasize, so the process tends to select for greater malignancy in the secondary tumour. The heterogeneity of tumours probably accounts for the difficulty of providing effective treatment, in that the various subpopulations of cells arising from each tumour vary in their responses to chemotherapeutic agents. We do not yet understand the process sufficiently to treat cancer patients by interfering selectively with the metastatic mechanisms.

摘要

恶性肿瘤导致疾病和死亡,主要是因为它们会侵袭和转移。肿瘤细胞的许多特性使得这种扩散成为可能,包括肿瘤细胞移动和释放降解酶的能力。这些特性使肿瘤细胞能够脱离原发肿瘤,穿透血管或淋巴管,并在被输送到远处部位后,穿出血管形成新的肿瘤。然而,肿瘤中的并非所有细胞都能够转移,因此这个过程往往会在继发性肿瘤中选择更具恶性的细胞。肿瘤的异质性可能是提供有效治疗存在困难的原因,因为每个肿瘤产生的各种细胞亚群对化疗药物的反应各不相同。我们对这个过程的了解还不够充分,无法通过选择性干扰转移机制来治疗癌症患者。

相似文献

1
Invasion and metastasis.侵袭与转移。
Can Med Assoc J. 1983 May 15;128(10):1164-7.
2
Invasion and metastasis: new approaches to an old problem.侵袭与转移:解决老问题的新方法。
Oncology (Williston Park). 1993 Apr;7(4):47-52; discussion 52, 57, 60-2.
3
Cancer dissemination--lessons from leukocytes.癌细胞转移——来自白细胞的启示。
Dev Cell. 2010 Jul 20;19(1):13-26. doi: 10.1016/j.devcel.2010.06.013.
4
The basement membrane matrix in malignancy.恶性肿瘤中的基底膜基质
J Pathol. 2003 Jul;200(4):465-70. doi: 10.1002/path.1396.
5
[When and why does cancer metastasize? An overview of current viewpoints OF the molecular mechanism of invasiveness].[癌症何时以及为何会发生转移?侵袭性分子机制的当前观点概述]
Verh K Acad Geneeskd Belg. 1994;56(2):105-25.
6
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.肿瘤细胞的迁移、侵袭与转移:神经递质介导的导航
Lancet Oncol. 2004 Apr;5(4):254-8. doi: 10.1016/S1470-2045(04)01431-7.
7
Role of integrins and other cell adhesion molecules in tumor progression and metastasis.整合素及其他细胞黏附分子在肿瘤进展和转移中的作用。
Lab Invest. 1993 Jan;68(1):4-17.
8
Mastering the intricate maze of metastasis.攻克转移这一错综复杂的难题。
Oncol Nurs Forum. 2001 Jul;28(6):959-65.
9
The paradox of neoplastic glial cell invasion of the brain and apparent metastatic failure.肿瘤性胶质细胞侵袭大脑与明显的转移失败的矛盾现象。
Anticancer Res. 1997 Nov-Dec;17(6B):4103-5.
10
[Tumor progression and metastasis].[肿瘤进展与转移]
Zentralbl Chir. 1990;115(13):785-92.

引用本文的文献

1
Keratin 6A (KRT6A) promotes radioresistance, invasion, and metastasis in lung cancer via p53 signaling pathway.角蛋白 6A(KRT6A)通过 p53 信号通路促进肺癌的放射抵抗、侵袭和转移。
Aging (Albany NY). 2024 Apr 17;16(8):7060-7072. doi: 10.18632/aging.205742.
2
Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology.基于单细胞技术探索肝癌转移相关生物标志物及致癌机制
Heliyon. 2024 Mar 7;10(6):e27473. doi: 10.1016/j.heliyon.2024.e27473. eCollection 2024 Mar 30.
3
High expression of serine protease 2 (PRSS2) associated with invasion, metastasis, and proliferation in gastric cancer.丝氨酸蛋白酶 2(PRSS2)的高表达与胃癌的侵袭、转移和增殖有关。
Aging (Albany NY). 2023 Mar 23;15(7):2473-2484. doi: 10.18632/aging.204604.
4
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies.肿瘤相关巨噬细胞在肿瘤进展中的作用:对治疗策略的启示
Exp Hematol Oncol. 2021 Dec 29;10(1):60. doi: 10.1186/s40164-021-00252-z.
5
Breast Cancer: A Global Concern, Diagnostic and Therapeutic Perspectives, Mechanistic Targets in Drug Development.乳腺癌:全球关注的问题、诊断与治疗前景、药物研发中的作用机制靶点
Adv Pharm Bull. 2021 Sep;11(4):580-594. doi: 10.34172/apb.2021.068. Epub 2020 Oct 14.
6
Fra-2 overexpression upregulates pro-metastatic cell-adhesion molecules, promotes pulmonary metastasis, and reduces survival in a spontaneous xenograft model of human breast cancer.Fra-2 过表达上调促转移细胞黏附分子,促进肺转移,并降低人乳腺癌自发异种移植模型中的存活率。
J Cancer Res Clin Oncol. 2022 Jun;148(6):1525-1542. doi: 10.1007/s00432-021-03812-2. Epub 2021 Oct 24.
7
Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells.载姜黄素介孔硅纳米粒子显著增强肝癌细胞的细胞毒性。
Int J Mol Sci. 2019 Jun 14;20(12):2918. doi: 10.3390/ijms20122918.
8
Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.侵袭和转移的分子和功能成像:转移级联的窗口。
Cancer Biomark. 2010;7(4):173-88. doi: 10.3233/CBM-2010-0188.
9
High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study.肿瘤周围淋巴管高密度是子宫内膜癌的一个潜在预后标志物:一项临床免疫组织化学方法研究。
BMC Cancer. 2010 Apr 8;10:131. doi: 10.1186/1471-2407-10-131.
10
Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate.转基因腺癌小鼠前列腺吸收性淋巴管中的肿瘤细胞跨内皮迁移
Am J Pathol. 2007 Jan;170(1):334-46. doi: 10.2353/ajpath.2007.060447.

本文引用的文献

1
Organ vascularity and metastatic frequency.器官血管分布与转移频率。
Am J Pathol. 1980 Oct;101(1):101-13.
2
Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential.具有不同肺定植潜能的B16黑色素瘤变体上膜阴离子位点的分布
Nature. 1980 Mar 27;284(5754):363-4. doi: 10.1038/284363a0.
3
Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.B16小鼠黑色素瘤细胞系中纤溶酶原激活物的产生与肿瘤转移的相关性。
Cancer Res. 1980 Feb;40(2):288-92.
4
The chemotactic response of tumor cells. A model for cancer metastasis.肿瘤细胞的趋化反应。癌症转移模型。
Am J Pathol. 1981 Jul;104(1):69-76.
5
Lysosomal cathepsin B: correlation with metastatic potential.溶酶体组织蛋白酶B:与转移潜能的相关性。
Science. 1981 Jun 5;212(4499):1151-3. doi: 10.1126/science.7233209.
6
Plasminogen activator activity and composition in human breast cancer.人类乳腺癌中的纤溶酶原激活物活性与成分
Cancer Res. 1982 Jan;42(1):219-26.
7
Localization of intravenously injected tumor cells in the rat mesentery after intraperitoneal administration of chemotactic stimuli.腹腔内给予趋化刺激后静脉注射的肿瘤细胞在大鼠肠系膜中的定位。
Invasion Metastasis. 1981;1(4):239-47.
8
Biological diversity in metastatic neoplasms: origins and implications.转移性肿瘤中的生物多样性:起源与影响
Science. 1982 Sep 10;217(4564):998-1003. doi: 10.1126/science.7112116.
9
Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.实验诱导的腹腔渗出液中肿瘤细胞补体衍生趋化因子的产生及其对循环肿瘤细胞局部转移的影响。
Am J Pathol. 1982 Jul;108(1):112-8.
10
Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers.利用血管内皮细胞单层进行转移性肿瘤细胞附着和侵袭试验。
J Histochem Cytochem. 1982 Mar;30(3):214-20. doi: 10.1177/30.3.7061823.